In the LYRICA treatment group, the adverse reactions most frequently leading to discontinuation were dizziness (6%), ataxia (4%), and somnolence (3%). In comparison, less than 1% of patients in the placebo group withdrew due to each of these events. The question of whether it is appropriate to restrict the circulation of pregabalin remains open.

• Advise patients that LYRICA may cause angioedema, with swelling of the face, mouth (lip, gum, tongue) and neck (larynx and pharynx) that can lead to life-threatening respiratory compromise.
• Instruct patients to discontinue LYRICA and immediately seek medical care if they experience these symptoms see Warnings and Precautions (5.1).
• After that, drugs containing it were withdrawn from circulation in a number of countries, and it began to be sold as a “designer drug” in the form of a dietary supplement, mainly at petrol stations, for which it was slangily named “gas station heroin” by the FDA 222.
• As the thiazolidinedione class of antidiabetic drugs can cause weight gain and/or fluid retention, possibly exacerbating or leading to heart failure, exercise caution when co-administering LYRICA and these agents.
• The mean t½ is 3 to 4 hours in pediatric subjects up to 6 years of age, and 4 to 6 hours in those 7 years of age and older.
• Fifty-three percent of the pregabalin-treated subjects compared to 33% of placebo patients remained on study drug and maintained a therapeutic response to Week 26 of the study.

What precautions should I know before taking Pregabalin?

In the current trial, a single preoperative buy pregabalin cheap dose of pregabalin 150 mg was beneficial in controlling pain intensity with an opioid-sparing effect for a period of 48 hr after arthroscopic shoulder surgery. Contradictory results found in previous studies evaluating the effect of pregabalin on acute postoperative pain might be related to different doses and the type of surgery. Given that both gabapentin and pregabalin are recommended as first-line treatment for chronic neuropathic pain, it is imperative to conduct a direct comparison between these two drugs (20). This comparison will provide more precise information regarding their efficacy and safety, as well as their impact on broader aspects of patients’ quality of life and functionality. Patient-reported outcome measures (PROMs) may actually have more health relevance in chronic pain for patients, professionals, and health administrators than the simple assessment of pain intensity (21). Twenty-three studies examined the effectiveness of pregabalin in treatment of peripheral neuropathic pain including diabetic peripheral neuropathy (DPN), PHN and herpes zoster (table 1).

4 Patient reported outcome measures (PROMs)

However, a higher incidence of nausea and vomiting was observed with gabapentin compared to pregabalin. According to the Canadian Pain Society, both medications are considered first-line treatments for chronic neuropathic pain, but guidelines caution about potential adverse effects such as drowsiness, dizziness, peripheral edema, and blurred vision (20). Our study revealed that gabapentin had an almost three-fold higher risk of causing nausea and vomiting compared to pregabalin. It is important to consider the recommended doses, such as 100–300 mg/day for gabapentin and 25–150 mg/day for pregabalin, according to the Canadian Society (20). The quality of the included studies examining efficacy of pregabalin for pain was rated as low or very low according to the GRADE framework. This highlights the need for larger, robust, high-quality clinical trials to be conducted, with particular attention paid to minimising selective reporting of outcomes.

Pregabalin Prices

In view of the dose-dependent adverse reactions, treatment with doses above 300 mg/day is not recommended see Adverse Reactions (6.1). Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of pregabalin in the elderly. However, elderly patients are more likely to have unwanted effects (eg, dizziness, blurred vision, confusion, or clumsiness) and age-related kidney problems, which may require an adjustment in the dose for patients receiving pregabalin. Though it helps many people, this medication may sometimes cause addiction. This risk may be higher if you have a substance use disorder (such as overuse of or addiction to drugs/alcohol).